Uncategorized

The MEDICREA Group: 2009 Half Year Results

LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris: ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture and sale of spinal implants, is publishing its 2009 half year results.

HALF YEAR RESULTS IN LINE WITH THE GROUP’S STRATEGY OF STRONG GROWTH

  • Sales of €6.1 million at June 30, 2009, up 32%
  • Recovery in gross margin
  • Bolstered commercial marketing and clinical studies investments, especially in the USA

H1 2009 RESULTS AND SALIENT FACTS

In € millions H1 2008 H2 2008 H1 2009 (1)

Net sales

Gross margin in %

Operating income

EBITDA (2)

Pretax income from ordinary activities

Income before goodwill amortization

Net income

4,6

68 %

(1,7)

(0,9)

(1,7)

(1,2)

(1,5)

4,4

51 %

(2,2)

(1,6)

(2,4)

(3,2)

(3,4)

6,1

64 %

(1,5)

(0,8)

(1,7)

(1,2)

(1,5)

(1) : Non audited half year accounts – French GAAP
(2) : EBITDA : Earnings before Interests, taxes, depreciation and amortization

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button